Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-021442
Filing Date
2010-03-05
Accepted
2010-03-05 13:34:31
Documents
15
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c97200e10vk.htm 10-K 636243
2 EXHIBIT 21.1 c97200exv21w1.htm EX-21.1 884
3 EXHIBIT 31.1 c97200exv31w1.htm EX-31.1 8847
4 EXHIBIT 31.2 c97200exv31w2.htm EX-31.2 8814
5 EXHIBIT 32.1 c97200exv32w1.htm EX-32.1 3352
6 EXHIBIT 32.2 c97200exv32w2.htm EX-32.2 3318
7 GRAPHIC c97200c9720001.gif GRAPHIC 3859
8 GRAPHIC c97200p9720002.jpg GRAPHIC 59569
9 GRAPHIC c97200c9720009.gif GRAPHIC 2901
10 GRAPHIC c97200c9720003.gif GRAPHIC 64530
11 GRAPHIC c97200c9720004.gif GRAPHIC 12137
12 GRAPHIC c97200c9720005.gif GRAPHIC 15135
13 GRAPHIC c97200c9720006.gif GRAPHIC 13202
14 GRAPHIC c97200p9720007.jpg GRAPHIC 64865
15 GRAPHIC c97200c9720008.gif GRAPHIC 47453
  Complete submission text file 0000950123-10-021442.txt   1055143
Mailing Address 100 N. FAIRWAY DRIVE SUITE 134 VERNON HILLS IL 60061
Business Address 100 N. FAIRWAY DRIVE SUITE 134 VERNON HILLS IL 60061 847-362-8200
Winston Pharmaceuticals, Inc. (Filer) CIK: 0001302554 (see all company filings)

EIN.: 300132755 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51314 | Film No.: 10659935
SIC: 2834 Pharmaceutical Preparations